XML 18 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Net (decrease) increase in net assets resulting from operations $ (1,714,212) $ 2,252,681
Adjustments to reconcile net (decrease) increase in net assets resulting from operations to net cash used in operating activities:    
Net change in unrealized (depreciation) appreciation on investments 3,444,211 (390,245)
Net change in unrealized appreciation or depreciation on obligations under participation agreements (42,128) (8,408)
Net realized gain on investments (55,783) (267,140)
Amortization and accretion of investment-related fees, net (731,252) (630,880)
Amortization of discount on debt issuance 273,293 102,729
Amortization of deferred financing costs 182,974 171,677
PIK interest income, net 0 (94,524)
Purchases of investments (48,077,115) (103,350,399)
Repayments and proceeds from sale of investments 42,927,659 77,879,346
Changes in operating assets and liabilities:    
Decrease (increase) in interest receivable 83,407 (660,753)
Decrease in prepaid expenses and other assets 259,480 103,179
Increase (decrease) in interest reserve and other deposits held on investments 35,996 (599,315)
Decrease in due to related party (3,108,922) 0
(Decrease) increase in due to Adviser, net (160,499) 168,793
Increase in accrued expenses 89,187 143,111
Increase (decrease) in interest payable from obligations under participation agreements 53,186 (93,618)
(Decrease) increase in other liabilities (378,215) 631,063
Net cash used in operating activities (6,918,733) (24,642,703)
Cash flows from financing activities:    
Proceeds from issuance of unsecured notes payable, net of discount 0 37,175,781
Proceeds from obligations under participation agreements 1,225,275 21,223,404
Repayment of obligations under participation agreements 0 (25,728,138)
Proceeds from borrowings under term loan payable 19,937,500 4,375,000
Payments of stockholder distributions (2,118,351) (2,165,692)
Payments of financing costs 0 (1,290,829)
Payments for repurchases of common stock 0 (1,881,229)
Net cash provided by financing activities 19,044,424 31,708,297
Net increase in cash, cash equivalents and restricted cash 12,125,691 7,065,594
Cash, cash equivalents and restricted cash, at beginning of period 12,456,874 14,302,689
Cash, cash equivalents and restricted cash, at end of period (Note 2) $ 24,582,565 $ 21,368,283